Targeting microbes and dysbiosis in severe asthma

J. Simpson (New Lambton, Australia)

Source: International Congress 2019 – Beyond T2 mechanisms in asthma: who are the other players?
Session: Beyond T2 mechanisms in asthma: who are the other players?
Session type: Hot topic
Number: 432
Disease area: Airway diseases

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Simpson (New Lambton, Australia). Targeting microbes and dysbiosis in severe asthma. International Congress 2019 – Beyond T2 mechanisms in asthma: who are the other players?

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Bacterial dysbiosis in pediatric lung diseases such as asthma and CF
Source: Virtual Congress 2020 – Bugs secret's: the way the microbiome changes our future
Year: 2020


The role of pathogenic bacterial colonisation in neutrophilic airways inflammation in severe asthma
Source: Annual Congress 2009 - Novel mechanisms in the pathogenesis of asthma
Year: 2009

Targeting the microbiome in respiratory diseases
Source: International Congress 2018 – Microbiomes in respiratory disease
Year: 2018


How does the gut microbiota regulate immune responses in the airways?
Source: Annual Congress 2006 - Can environmental exposures prevent allergic disease, what are the mechanisms and how important is timing of exposure?
Year: 2006


Azurocidin-1: a marker of COPD severity and microbial dysbiosis
Source: Virtual Congress 2020 – Biomarkers and characterisation of immune response in respiratory infection
Year: 2020


Role of atypical bacterial infections in exacerbation of asthma in children
Source: Eur Respir J 2005; 26: Suppl. 49, 165s
Year: 2005

Lactase deficiency and intestinal microbiota of patients with asthma.
Source: International Congress 2017 – Primary care management of respiratory symptoms, allergies, inhalers and adherence
Year: 2017


The environmental microbiota and asthma
Source: Eur Respir Monogr 2019; 83: 216-239
Year: 2019


Interactions between antiviral and atopic inflammatory pathways sustain asthma exacerbations in children
Source: Annual Congress 2009 - Infections, immunity and inflammation
Year: 2009

Role of viral pathogens in infectious exacerbations of bronchial asthma in adults
Source: Annual Congress 2012 - Asthma: assessment and treatment
Year: 2012

Early childhood respiratory infections do not protect against asthma and atopic disease
Source: ISSN=ISSN 1810-6838, ISBN=, page=261
Year: 2006

Differential inflammatory effects of colonising airway bacteria in COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 686s
Year: 2004

Role of neutrophils in airway inflammation in children with severe persistent asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 142s
Year: 2002

The airway microbiota and exacerbations of COPD
Source: ERJ Open Res, 6 (3) 00168-2020; 10.1183/23120541.00168-2020
Year: 2020



The microbiome in chronic respiratory diseases
Source: International Congress 2017 – Can we translate the microbiome from basic science to clinical practice?
Year: 2017


Viral and bacterial etiology of severe COPD exacerbations: relationship with airway inflammation
Source: Eur Respir J 2005; 26: Suppl. 49, 251s
Year: 2005

Host–microbe interactions in distal airways: relevance to chronic airway diseases
Source: Eur Respir Rev 2015; 24: 78-91
Year: 2015



The role of atypical pathogens in acute exacerbations of bronchial asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 503s
Year: 2006

Spectrum of sputum microflora during infectious exacerbation of bronchial asthma
Source: Annual Congress 2009 - Asthma and comorbid conditions
Year: 2009